Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 8, 2013 - Issue 3
Submit an article Journal homepage
82
Views
3
CrossRef citations to date
0
Altmetric
Review

Thermogenesis-based interventions for obesity and Type 2 diabetes mellitus

Sunil J Wimalawansa Department of Medicine, Endocrinology, Metabolism & Nutrition, UMDNJ-RWJMS, New Brunswick, NJ 08903, USA. [email protected]
Pages 275-288 | Published online: 10 Jan 2014

References

  • Wong K, Glovaci D, Malik S et al. Comparison of demographic factors and cardiovascular risk factor control among US adults with Type 2 diabetes by insulin treatment classification. J. Diabetes Complicat. 26(3), 169–174 (2012).
  • Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong ND. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int. J. Obes. (Lond.) 33(2), 239–248 (2009).
  • King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabet. Care 21(9), 1414–1431 (1998).
  • WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation in obesity. WHO, Geneva, Switzerland (1998).
  • NIH. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – The Evidence Report. Obes. Res. 6(Suppl. 2), 51S–209S (1998).
  • Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch. Intern. Med. 158(17), 1855–1867 (1998).
  • Ma MH, Chen SY, Chiang WC, Su CP, Chen WJ. A clinical prediction rule for the severe acute respiratory syndrome. Ann. Intern. Med. 142(3), 225; author reply 225–225; author reply 226 (2005).
  • Anderson JW, Konz EC. Obesity and disease management: effects of weightloss on comorbid conditions. Obes. Res. 9(Suppl. 4), 326S–334S (2001).
  • Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief 82, 1–8 (2012).
  • Fakhouri TH, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity among older adults in the United States, 2007–2010. NCHS Data Brief 106, 1–8 (2012).
  • Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am. J. Med. Sci. 331(4), 166–174 (2006).
  • Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303(3), 235–241 (2010).
  • Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA 303(3), 242–249 (2010).
  • Berrington de Gonzalez A, Hartge P, Cerhan JR. Body-mass index and mortality among 1.46 million white adults. N. Engl. J. Med. 363(23), 2211–2219 (2010).
  • Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists’ position statement on obesity and obesity medicine. Endocr. Pract. 18(5), 642–648 (2012).
  • Smith SC Jr. Multiple risk factors for cardiovascular disease and diabetes mellitus. Am. J. Med. 120(3 Suppl. 1), S3–S11 (2007).
  • Losina E, Walensky RP, Reichmann WM et al. Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann. Intern. Med. 154(4), 217–226 (2011).
  • Pouliot MC, Després JP, Lemieux S et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am. J. Cardiol. 73(7), 460–468 (1994).
  • Barabási AL. Network medicine – from obesity to the ‘diseasome’. N. Engl. J. Med. 357(4), 404–407 (2007).
  • Dudeja V, Misra A, Pandey RM, Devina G, Kumar G, Vikram NK. BMI does not accurately predict overweight in Asian Indians in northern India. Br. J. Nutr. 86(1), 105–112 (2001).
  • Grabner M. BMI trends, socioeconomic status, and the choice of dataset. Obes. Facts 5(1), 112–126 (2012).
  • Bigaard J, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, Sørensen TI. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes. Res. 11(7), 895–903 (2003).
  • Wimalawansa SJ. Visceral adiposity and cardiometabolic risks: epidemic of abdominal obesity in North America. Research and Reports in Endocrine Disorders 3, 1–14 (2013).
  • Chan VO, McDermott S, Buckley O et al. The relationship of body mass index and abdominal fat on the radiation dose received during routine computed tomographic imaging of the abdomen and pelvis. Can. Assoc. Radiol. J. 63(4), 260–266 (2012).
  • Xu L, Cheng X, Wang J et al. Comparisons of body-composition prediction accuracy: a study of 2 bioelectric impedance consumer devices in healthy Chinese persons using DXA and MRI as criteria methods. J. Clin. Densitom. 14(4), 458–464 (2011).
  • Bredella MA, Ghomi RH, Thomas BJ et al. Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring) 18(11), 2227–2233 (2010).
  • Chinn PL. Healthy People beyond 2010. ANS. Adv. Nurs. Sci. 32(4), 281 (2009).
  • Paeratakul S, White MA, Williamson DA, Ryan DH, Bray GA. Sex, race/ethnicity, socioeconomic status, and BMI in relation to self-perception of overweight. Obes. Res. 10(5), 345–350 (2002).
  • Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 132(6), 2087–2102 (2007).
  • CDC. Healthy People 2010 Final Review 2011. CDC, Atlanta, GA, USA (2011).
  • Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444(7121), 881–887 (2006).
  • Howel D. Waist circumference and abdominal obesity among older adults: patterns, prevalence and trends. PLoS ONE 7(10), e48528 (2012).
  • Arsenault BJ, Lachance D, Lemieux I et al. Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch. Intern. Med. 167(14), 1518–1525 (2007).
  • Smith JD, Borel AL, Nazare JA et al. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without Type 2 diabetes: results from the INSPIRE ME IAA study. J. Clin. Endocrinol. Metab. 97(5), 1517–1525 (2012).
  • Asakawa H, Tokunaga K, Kawakami F. Relationship of abdominal fat with metabolic disorders in diabetes mellitus patients. Diabetes Res. Clin. Pract. 55(2), 139–149 (2002).
  • Gautier JF, Mourier A, de Kerviler E et al. Evaluation of abdominal fat distribution in noninsulin-dependent diabetes mellitus: relationship to insulin resistance. J. Clin. Endocrinol. Metab. 83(4), 1306–1311 (1998).
  • Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145(5), 2273–2282 (2004).
  • Brychta R, Wohlers E, Moon J, Chen K. Energy expenditure: measurement of human metabolism. IEEE Eng. Med. Biol. Mag. 29(1), 42–47 (2010).
  • Black AE, Coward WA, Cole TJ, Prentice AM. Human energy expenditure in affluent societies: an analysis of 574 doubly-labelled water measurements. Eur. J. Clin. Nutr. 50(2), 72–92 (1996).
  • Cannon CP. The endocannabinoid system: a new approach to control cardiovascular disease. Clin. Cornerstone 7(2–3), 17–26 (2005).
  • Szmitko PE, Verma S. The endocannabinoid system and cardiometabolic risk. Atherosclerosis 199(2), 248–256 (2008).
  • Blüher M, Engeli S, Klöting N et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55(11), 3053–3060 (2006).
  • Di Marzo V. The endocannabinoid system in obesity and Type 2 diabetes. Diabetologia 51(8), 1356–1367 (2008).
  • Nicklas BJ, Ambrosius W, Messier SP et al. Diet-induced weightloss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am. J. Clin. Nutr. 79(4), 544–551 (2004).
  • Bouchard C, Dionne FT, Simoneau JA, Boulay MR. Genetics of aerobic and anaerobic performances. Exerc. Sport Sci. Rev. 20, 27–58 (1992).
  • Eisenmann JC, Katzmarzyk PT, Perusse L, Tremblay A, Després JP, Bouchard C. Aerobic fitness, body mass index, and CVD risk factors among adolescents: the Québec family study. Int. J. Obes. (Lond.) 29(9), 1077–1083 (2005).
  • Karelis AD, Faraj M, Bastard JP et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J. Clin. Endocrinol. Metab. 90(7), 4145–4150 (2005).
  • Janiszewski PM, Ross R. Effects of weightloss among metabolically healthy obese men and women. Diabetes Care 33(9), 1957–1959 (2010).
  • Janssen I. Heart disease risk among metabolically healthy obese men and metabolically unhealthy lean men. CMAJ 172(10), 1315–1316 (2005).
  • Esposito K, Pontillo A, Di Palo C et al. Effect of weightloss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289(14), 1799–1804 (2003).
  • Arsenault BJ, Cartier A, Côté M et al. Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women. Am. J. Cardiol. 104(2), 240–246 (2009).
  • Hamer M, Batty GD, Kivimaki M. Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing. Mol. Psychiatry 17(9), 940–945 (2012).
  • Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 97(7), 2482–2488 (2012).
  • Blüher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr. Opin. Lipidol. 21(1), 38–43 (2010).
  • Zhao G, Ford ES, Li C, Tsai J, Dhingra S, Balluz LS. Waist circumference, abdominal obesity, and depression among overweight and obese US adults: National Health and Nutrition Examination Survey 2005–2006. BMC Psychiatry 11, 130 (2011).
  • Misra A, Vikram NK, Gupta R, Pandey RM, Wasir JS, Gupta VP. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int. J. Obes. (Lond.) 30(1), 106–111 (2006).
  • Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered bodyweight. N. Engl. J. Med. 332(10), 621–628 (1995).
  • Swinburn B, Sacks G, Ravussin E. Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am. J. Clin. Nutr. 90(6), 1453–1456 (2009).
  • Tsai F, Coyle WJ. The microbiome and obesity: is obesity linked to our gut flora? Curr. Gastroenterol. Rep. 11(4), 307–313 (2009).
  • Lallès JP. Long term effects of pre- and early-postnatal nutrition and environment on the gut. J. Anim. Sci. 90(Suppl. 4), 421–429 (2012).
  • Zoetendal EG, Cheng B, Koike S, Mackie RI. Molecular microbial ecology of the gastrointestinal tract: from phylogeny to function. Curr. Issues Intest. Microbiol. 5(2), 31–47 (2004).
  • Romanatto T, Cesquini M, Amaral ME et al. TNF-α acts in the hypothalamus inhibiting food intake and increasing the respiratory quotient–effects on leptin and insulin signaling pathways. Peptides 28(5), 1050–1058 (2007).
  • Eriksson KF, Lindgärde F. Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 34(12), 891–898 (1991).
  • Yoshioka M, Doucet E, St-Pierre S et al. Impact of high-intensity exercise on energy expenditure, lipid oxidation and body fatness. Int. J. Obes. Relat. Metab. Disord. 25(3), 332–339 (2001).
  • Yamaoka K, Tango T. Efficacy of lifestyle education to prevent Type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 28(11), 2780–2786 (2005).
  • Cannon CP, Kumar A. Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options. Clin. Cornerstone 9(4), 55–68; discussion 69 (2009).
  • Belza A, Gille MB, Schultz John S, Kondrup J. The β-adrenergic antagonist propranolol partly abolishes thermogenic response to bioactive food ingredients. Metab. Clin. Exp. 58(8), 1137–1144 (2009).
  • White DK, Neogi T, Zhang Y et al. The association of obesity with walking independent of knee pain: the multicenter osteoarthritis study. J. Obes. 2012, 261974 (2012).
  • Levine JA, McCrady SK, Lanningham-Foster LM, Kane PH, Foster RC, Manohar CU. The role of free-living daily walking in human weight gain and obesity. Diabetes 57(3), 548–554 (2008).
  • Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298(17), 2028–2037 (2007).
  • Ervin RB, Kit BK, Carroll MD, Ogden CL. Consumption of added sugar among US children and adolescents, 2005–2008. NCHS Data Brief 87, 1–8 (2012).
  • Fakhouri TH, Kit BK, Ogden CL, Consumption of diet drinks in the United States, 2009–2010. NCHS Data Brief 109, 1–8 (2012).
  • Montague MC, Broadnax PA. Health consequences of excess weight and obesity. J. Natl Black Nurses. Assoc. 15(1), 24–31 (2004).
  • Dengel DR, Pratley RE, Hagberg JM, Rogus EM, Goldberg AP. Distinct effects of aerobic exercise training and weightloss on glucose homeostasis in obese sedentary men. J. Appl. Physiol. 81(1), 318–325 (1996).
  • Cooper JN, Columbus ML, Shields KJ et al. Effects of an intensive behavioral weightloss intervention consisting of caloric restriction with or without physical activity on common carotid artery remodeling in severely obese adults. Metab. Clin. Exp. 61(11), 1589–1597 (2012).
  • Strasser B. Physical activity in obesity and metabolic syndrome. Ann. N. Y. Acad. Sci. 1281(1), 141–159 (2012).
  • Jakicic JM. Physical activity and weightloss. Nestle. Nutr. Inst. Workshop Ser. 73, 21–36 (2012).
  • Poehlman ET, Dvorak RV, DeNino WF, Brochu M, Ades PA. Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial. J. Clin. Endocrinol. Metab. 85(7), 2463–2468 (2000).
  • Irwin ML, Yasui Y, Ulrich CM et al. Effect of exercise on total and intra-abdominal bodyfat in postmenopausal women: a randomized controlled trial. JAMA 289(3), 323–330 (2003).
  • Ross R, Dagnone D, Jones PJ et al. Reduction in obesity and related comorbid conditions after diet-induced weightloss or exercise-induced weightloss in men. A randomized, controlled trial. Ann. Intern. Med. 133(2), 92–103 (2000).
  • Ready AE, Drinkwater DT, Ducas J, Fitzpatrick DW, Brereton DG, Oades SC. Walking program reduces elevated cholesterol in women postmenopause. Can. J. Cardiol. 11(10), 905–912 (1995).
  • Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation 117(23), 3031–3038 (2008).
  • Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 281(18), 1722–1727 (1999).
  • Church TS, Earnest CP, Skinner JS, Blair SN. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA 297(19), 2081–2091 (2007).
  • Ryan DH, Espeland MA, Foster GD et al.; Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weightloss for the prevention of cardiovascular disease in Type 2 diabetes. Control. Clin. Trials 24(5), 610–628 (2003).
  • Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF. Trying to lose weight, losing weight, and 9-year mortality in overweight US adults with diabetes. Diabetes Care 27(3), 657–662 (2004).
  • Eriksson B, Löf M, Olausson H, Forsum E. Bodyfat, insulin resistance, energy expenditure and serum concentrations of leptin, adiponectin and resistin before, during and after pregnancy in healthy Swedish women. Br. J. Nutr. 103(1), 50–57 (2010).
  • Heilbronn LK, Rood J, Janderova L et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 89(4), 1844–1848 (2004).
  • Cowie CC, Rust KF, Ford ES et al. Full accounting of diabetes and pre-diabetes in the US population in 1988–1994 and 2005–2006. Diabetes Care 32(2), 287–294 (2009).
  • Belalcazar LM, Reboussin DM, Haffner SM et al.; Look AHEAD Research Group. A 1-year lifestyle intervention for weightloss in individuals with Type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 33(11), 2297–2303 (2010).
  • Wadden TA, West DS, Delahanty L et al.; Look AHEAD Research Group. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring) 14(5), 737–752 (2006).
  • Neiberg RH, Wing RR, Bray GA et al.; Look AHEAD Research Group. Patterns of weight change associated with long-term weight change and cardiovascular disease risk factors in the Look AHEAD Study. Obesity (Silver Spring) 20(1C0), 2048–2056 (2012).
  • Faulconbridge LF, Wadden TA, Rubin RR et al.; Look AHEAD Research Group. One-year changes in symptoms of depression and weight in overweight/obese individuals with Type 2 diabetes in the Look AHEAD study. Obesity (Silver Spring) 20(4), 783–793 (2012).
  • Gibbs BB, Brancati FL, Chen H et al. Effect of improved fitness beyond weightloss on cardiovascular risk factors in individuals with Type 2 diabetes in the Look AHEAD study. Eur. J. Prev. Cardiol. PMID:23012688 (2012) (Epub ahead of print).
  • Westman EC, Feinman RD, Mavropoulos JC et al. Low-carbohydrate nutrition and metabolism. Am. J. Clin. Nutr. 86(2), 276–284 (2007).
  • Eaton SB. The ancestral human diet: what was it and should it be a paradigm for contemporary nutrition? Proc. Nutr. Soc. 65(1), 1–6 (2006).
  • Karyadi D, Lukito W. Functional food and contemporary nutrition-health paradigm: tempeh and its potential beneficial effects in disease prevention and treatment. Nutrition 16(7–8), 697 (2000).
  • Ogden CL, Kit BK, Carroll MD, Park S. Consumption of sugar drinks in the United States, 2005–2008. NCHS Data Brief 71, 1–8 (2011).
  • Wright JD, Wang CY. Trends in intake of energy and macronutrients in adults from 1999–2000 through 2007–2008. NCHS Data Brief 49, 1–8 (2010).
  • CDC. Trends in intake of energy and macronutrients – United States, 1971–2000. MMWR Morb. Mortal Wkly Rep. 53(4), 80–82 (2004).
  • Bravata DM, Sanders L, Huang J et al. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA 289(14), 1837–1850 (2003).
  • Westman EC, Mavropoulos J, Yancy WS, Volek JS. A review of low-carbohydrate ketogenic diets. Curr. Atheroscler. Rep. 5(6), 476–483 (2003).
  • Fromme T, Klingenspor M. Uncoupling protein 1 expression and high-fat diets. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300(1), R1–R8 (2011).
  • Clarke SD, Gasperikova D, Nelson C, Lapillonne A, Heird WC. Fatty acid regulation of gene expression: a genomic explanation for the benefits of the mediterranean diet. Ann. N. Y. Acad. Sci. 967, 283–298 (2002).
  • Tsi D, Nah AK, Kiso Y, Moritani T, Ono H. Clinical study on the combined effect of capsaicin, green tea extract and essence of chicken on bodyfat content in human subjects. J. Nutr. Sci. Vitaminol. 49(6), 437–441 (2003).
  • Westerterp-Plantenga M, Diepvens K, Joosen AM, Bérubé-Parent S, Tremblay A. Metabolic effects of spices, teas, and caffeine. Physiol. Behav. 89(1), 85–91 (2006).
  • Kovacs EM, Mela DJ. Metabolically active functional food ingredients for weight control. Obes. Rev. 7(1), 59–78 (2006).
  • Diepvens K, Westerterp KR, Westerterp-Plantenga MS. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292(1), R77–R85 (2007).
  • Hursel R, Westerterp-Plantenga MS. Thermogenic ingredients and bodyweight regulation. Int. J. Obes. (Lond.) 34(4), 659–669 (2010).
  • Hyman M. Systems biology, toxins, obesity, and functional medicine. Altern. Ther. Health Med. 13(2), S134–S139 (2007).
  • Gillman MW, Barker D, Bier D et al. Meeting report on the 3rd International Congress on Developmental Origins of Health and Disease (DOHaD). Pediatr. Res. 61(5 Pt 1), 625–629 (2007).
  • Svacinová H, Matoulek M. Physical activity in the treatment of obesity. Vnitr. Lek. 56(10), 1069–1073 (2010).
  • Baroncelli GI, Bertelloni S, Sodini F, Saggese G. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD. Clin. Endocrinol. (Oxf.) 60(2), 175–184 (2004).
  • Davidson LE, Hudson R, Kilpatrick K et al. Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial. Arch. Intern. Med. 169(2), 122–131 (2009).
  • Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am. J. Clin. Nutr. 69(3), 373–380 (1999).
  • Wei M, Kampert JB, Barlow CE et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 282(16), 1547–1553 (1999).
  • Wei M. Cardiorespiratory fitness, adiposity, and mortality. JAMA 299(9), 1013; author reply 1014 (2008).
  • Church TS, Cheng YJ, Earnest CP et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care 27(1), 83–88 (2004).
  • Perseghin G, Price TB, Petersen KF et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N. Engl. J. Med. 335(18), 1357–1362 (1996).
  • Burstein R, Epstein Y, Shapiro Y, Charuzi I, Karnieli E. Effect of an acute bout of exercise on glucose disposal in human obesity. J. Appl. Physiol. 69(1), 299–304 (1990).
  • Janiszewski P. Physical activity in the management of visceral obesity and related disorders. In: Abdominal Obesity and the Endocannabinoid System: From Basic Aspects to Clinical Management of Related Cardiometabolic Risks. Despres JP (Ed.). Informa Healthcare, New York, NY, USA, 89–104 (2008).
  • Li M, Cheung BM. Pharmacotherapy for obesity. Br. J. Clin. Pharmacol. 68(6), 804–810 (2009).
  • Wadden TA, Volger S, Sarwer DB et al. A two-year randomized trial of obesity treatment in primary care practice. N. Engl. J. Med. 365(21), 1969–1979 (2011).
  • Wadden TA, Berkowitz RI, Womble LG et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N. Engl. J. Med. 353(20), 2111–2120 (2005).
  • Ryan DH, Johnson WD, Myers VH et al. Nonsurgical weightloss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Arch. Intern. Med. 170(2), 146–154 (2010).
  • Gyárfás I, Keltai M, Salim Y. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries in a case-control study based on the INTERHEART study. Orv. Hetil. 147(15), 675–686 (2006).
  • Yusuf S, Hawken S, Ounpuu S et al.; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438), 937–952 (2004).
  • Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37(12), 1595–1607 (1988).
  • DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14(3), 173–194 (1991).
  • Turner RC, Millns H, Neil HA et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316(7134), 823–828 (1998).
  • Mozersky RP, Bahl VK, Patel H et al. Hyperinsulinemia and coronary artery disease risk factors in patients with non-insulin-dependent diabetes mellitus and nondiabetics. J. Am. Osteopath. Assoc. 96(10), 591–596 (1996).
  • UK-PDS-33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes. UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131), 837–853 (1998).
  • UK-PDS-34. Effect of intensive blood-glucose control with metformin on complications in overweight patients with Type 2 diabetes. UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131), 854–865 (1998).
  • Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N. Engl. J. Med. 329(5), 304–309 (1993).
  • DCCT-1994. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J. Pediatr. 125(2), 177–188 (1994).
  • DCCT-1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329(14), 977–986 (1993).
  • Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321(7258), 405–412 (2000).
  • Moss SE, Klein R, Klein BE, Meuer SM. The association of glycemia and cause-specific mortality in a diabetic population. Arch. Intern. Med. 154(21), 2473–2479 (1994).
  • Khaw KT, Wareham N, Luben R et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322(7277), 15–18 (2001).
  • Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser. 894, i–xii, 1–253 (2000).
  • Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E; Obesity Canada Clinical Practice Guidelines Expert Panel. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 176(8), S1–S13 (2007).
  • Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J. Clin. Endocrinol. Metab. 85(8), 2970–2973 (2000).
  • Devaraj S, Rosenson RS, Jialal I. Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. Endocrinol. Metab. Clin. North Am. 33(2), 431–453, table of contents (2004).
  • Carpenter MA, Bodansky HJ. Drug treatment of obesity in Type 2 diabetes mellitus. Diabet. Med. 7(2), 99–104 (1990).
  • Tuomilehto J. Point: a glucose tolerance test is important for clinical practice. Diabetes Care 25(10), 1880–1882 (2002).
  • Nienhuis HE, Rongen-Westerlaken C, Wit JM et al. Results of long-term therapy with growth hormone in two dose regimens in Turner syndrome. Dutch Growth Hormone Working Group. Horm. Res. 39(Suppl. 2), 31–36 (1993).
  • Després JP, Lemieux S, Lamarche B et al. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Int. J. Obes. Relat. Metab. Disord. 19(Suppl. 1), S76–S86 (1995).
  • Katzmarzyk PT, Leon AS, Wilmore JH et al. Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Med. Sci. Sports Exerc. 35(10), 1703–1709 (2003).
  • Orchard TJ, Temprosa M, Goldberg R et al.; Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann. Intern. Med. 142(8), 611–619 (2005).
  • Newbold RR. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens) 9(3), 206–217 (2010).
  • Thayer KA, Heindel JJ, Bucher JR, Gallo MA. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ. Health Perspect. 120(6), 779–789 (2012).
  • Major GC, Doucet E, Trayhurn P, Astrup A, Tremblay A. Clinical significance of adaptive thermogenesis. Int. J. Obes. (Lond.) 31(2), 204–212 (2007).
  • Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 308(11), 1113–1121 (2012).
  • Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J. Steroid Biochem. Mol. Biol. 127(1–2), 27–34 (2011).
  • Newbold RR. Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life. Am. J. Clin. Nutr. 94(Suppl. 6), 1939S–1942S (2011).
  • Trasande L, Attina TM, Sathyanarayana S, Spanier AJ, Blustein J. Race/ethnicity-specific associations of urinary phthalates with childhood body mass in a nationally representative sample. Environ. Health Perspect. 121(4), 501–506 (2013).
  • Frederiksen H, Aksglaede L, Sorensen K, Skakkebaek NE, Juul A, Andersson AM. Urinary excretion of phthalate metabolites in 129 healthy Danish children and adolescents: estimation of daily phthalate intake. Environ. Res. 111(5), 656–663 (2011).
  • Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult US males. Environ. Health Perspect. 115(6), 876–882 (2007).
  • Yen TH, Lin-Tan DT, Lin JL. Food safety involving ingestion of foods and beverages prepared with phthalate-plasticizer-containing clouding agents. J. Formos. Med. Assoc. 110(11), 671–684 (2011).
  • Wang T, Li M, Chen B et al. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J. Clin. Endocrinol. Metab. 97(2), E223–E227 (2012).
  • Mineo PM, Cassell EA, Roberts ME, Schaeffer PJ. Chronic cold acclimation increases thermogenic capacity, non-shivering thermogenesis and muscle citrate synthase activity in both wild-type and brown adipose tissue deficient mice. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 161(4), 395–400 (2012).
  • Yoshida K, Konishi M, Nagashima K, Saper CB, Kanosue K. Fos activation in hypothalamic neurons during cold or warm exposure: projections to periaqueductal gray matter. Neuroscience 133(4), 1039–1046 (2005).
  • Kozak LP, Koza RA. Mitochondria uncoupling proteins and obesity: molecular and genetic aspects of UCP1. Int. J. Obes. Relat. Metab. Disord. 23(Suppl. 6), S33–S37 (1999).
  • Madden CJ, Tupone D, Cano G, Morrison SF. α2 Adrenergic receptor-mediated inhibition of thermogenesis. J. Neurosci. 33(5), 2017–2028 (2013).
  • Marette A, Bukowiecki LJ. Noradrenaline stimulates glucose transport in rat brown adipocytes by activating thermogenesis. Evidence that fatty acid activation of mitochondrial respiration enhances glucose transport. Biochem. J. 277(Pt 1), 119–124 (1991).
  • Xi D, Gandhi N, Lai M, Kublaoui BM. Ablation of Sim1 neurons causes obesity through hyperphagia and reduced energy expenditure. PLoS ONE 7(4), e36453 (2012).
  • Henriksen EJ. Invited review: effects of acute exercise and exercise training on insulin resistance. J. Appl. Physiol. 93(2), 788–796 (2002).
  • Mechanick JI, Kushner RF, Sugerman HJ et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr. Pract. 14(Suppl. 1), 1–83 (2008).
  • Livingston EH. The incidence of bariatric surgery has plateaued in the US Am. J. Surg. 200(3), 378–385 (2010).
  • Ogden CL, Lamb MM, Carroll MD, Flegal KM. Obesity and socioeconomic status in adults: United States, 2005–2008. NCHS Data Brief 50, 1–8 (2010).
  • Mechanick JI. Bariatric surgery and the role of the clinical endocrinologist: 2011 update. Endocr. Pract. 17(5), 788–797 (2011).
  • Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292(14), 1724–1737 (2004).
  • Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet 366(9491), 1059–1062 (2005).
  • Janiszewski PM, Janssen I, Ross R. Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors? Diabetes Care 30(12), 3105–3109 (2007).
  • Yusuf S, Hawken S, Ounpuu S et al.; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study. Lancet 366(9497), 1640–1649 (2005).
  • Lemieux I, Pascot A, Couillard C et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102(2), 179–184 (2000).
  • Lemieux I, Poirier P, Bergeron J et al. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can. J. Cardiol. 23(Suppl. B), 23B–31B (2007).
  • Arsenault BJ, Lemieux I, Després JP et al. The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ 182(13), 1427–1432 (2010).
  • NIH. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am. J. Clin. Nutr. 68(4), 899–917 (1998).
  • NHLBI – The Practical Guide. Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. In: Obesity Education Initiative. NHLBI, Bethesda, MD, USA (2000).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.